SPML Infra Limited — Major Shareholding Notification 2021

Sep 14, 2021

SBICAP Trustee Company Ltd.

Ref No :2488/STCL/2021-22

13th September, 2021

To SPML Infra Limited, F-27 /2, Okhla Industrial Area Phase II, New Delhi, Delhi - 110020.

Dear Sir,

Sub: Disclosures under Regulation 29(2) of SEBI {Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Please find attached the Disclosures which are required to be made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

You are requested to take note of the same on your records.

G www.sbicaptrustee.com

I!! +91 22 4302 5566 +91 22 4302 5555 @I +91 22 2204 0465 ^B corporate@sblcaptrustee.com

Corporate Office : 4th Floor, Mistry Bhavan, 122, Dinshaw Vachha Road, Churchgate, Mumbai, Pin - 400 020. A Group Company of SB/

Registered Office : 202, Maker Tower E, Cuffe Parade, Mumbai - 400 005.

CIN : U65991MH2005PLC158386

Format for disclosures under Regulation 29(2) ofSEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 20 I I

Name of the Target Company (TC)	SPML Infra Limited SBICAP Trustee Company Limited No Bombay Stock Exchange and National Stock Exchange
Name(s) of the acquirer and Acting in Concert Persons (PAC) with acquirer the
Whether the acquirer belongs to Promoter/Promoter group
of the Exchange(s) where Name(s) Stock the shares of TC Listed are
Details acquisition I disposal as of the follows	Number	% w.r.t.total share/votin g capital wherever applicable( *)	% w.r.t. total diluted share/voti capital ng of the TC (**)
Before acquisition/sele/eeleese the under consideration, holding of: a) carrying voting rights Shares b) Shares in the (pledge/ of encumbrance nature lien/ disposal undertaking/ others) non Voting rights (YR) c) otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer receive to carrying voting rights in (specify shares the T C	b) 42,41,297	b) 11.57	b) 11.57
holding in each category) e) (a+b+c+d) Total	e) 42,41,297	e) 11.57	e) 11.57
Details of acq uisitionlsalelFelease a) Shares carrying voting rights acquired/sold b) acquired /sold VRs otherwise than by shares c) securities/any Warrants/convertible other instrument that acquirer entitles the receive to shares carrying voting rights (specify in the TC holding in each acquired/sold category) d) Shares by the encumbered /invoked/released acquirer (a+b+c+/-d) e) Total	d) 60,100 e) 60,100	d) 0.16 e) 0.16	d) 0.16 e)0.16

After the acquisition/sale/release, holding of:
Shares carrying voting a) rights b) Shares acquirer encumbered with the c) than by VRs otherwise shares d) Warrants/convertible securities/any other instrument that entitles the acquirer receive to shares carrying voting rights in the (specify TC holding in each category) after acquisition (a+b+c+d) e) Total	b) 43,01,397	b) 1173	b) 1173
	e) 43,01,397	I e) 1173	e) 11 73
Mode of acquisition I sale (e.g. market I off- open I public issue I rights market issue preferential / allotment I inter-se transfer etc).	Pledge of Shares I
acquisition I sale Date of of shares I VR date of or receipt of intimation of allotment of shares, whichever is	of Acquisition Date : 09/09/2021
Equity_share ??p.ital I total voting capital of the TC the said /sale/release acquisitron	before13,66,so,276 equity shares ofRs.2/- each aggregating Rs 7 33 00 552/- bo o , · , ,
Equi?share _c??ital/ total voting capital of after the TC the said /sale/release acquisrtion I	3,66,50,276 equity shares of Rs.2/- each !aggregating 7,33,00,552/- Rs.
T?taldiluted share/voting capital I of the TC after the PI edge said	13.,66,50,276 equity shares of Rs.2/- each aggregating Rs. 7,33,00,552/-

(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

Place: Mumbai Date: 13/09/2021

Authorized Signatory